PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

High Risk Patients ◽

Effectiveness Analysis ◽

A COST EFFECTIVENESS ANALYSIS (CEA) COMPARING THE PURE-VU SYSTEM TO STANDARD COLONOSCOPY IN AVERAGE AND HIGH-RISK PATIENTS PRESENTING WITH INADEQUATELY PREPPED COLONS

10.1055/s-0040-1704802 ◽

2020 ◽

Author(s):

I Gralnek ◽

J Voigt ◽

S Nussbaum

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Risk Patients ◽

Standard Colonoscopy

Cost-Effectiveness Analysis of Invasive and Noninvasive Tests in High Risk Patients Treated With Amiodarone After Acute Myocardial Infarction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(98)00171-5 ◽

1998 ◽

Vol 31 (7) ◽

pp. 1481-1489 ◽

Cited By ~ 3

Author(s):

Roberto F.E Pedretti ◽

Giovanni B Migliori ◽

Vittorio Mapelli ◽

Gabriele Daniele ◽

Philip J Podrid ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Cost Effectiveness ◽

High Risk ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Risk Patients ◽

Noninvasive Tests

Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain

Advances in Therapy ◽

10.1007/s12325-018-0813-y ◽

2018 ◽

Vol 35 (11) ◽

pp. 1920-1934 ◽

Cited By ~ 4

Author(s):

Miguel Salavert ◽

Javier Cobo ◽

Álvaro Pascual ◽

Belén Aragón ◽

Stefano Maratia ◽

...

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Standard Of Care ◽

High Risk Patients ◽

Recurrent Clostridium Difficile Infection ◽

Effectiveness Analysis ◽

PST3 CLOPIDOGREL VERSUS ASPIRIN IN HIGH-RISK PATIENTS WITH RECENT ISCHEMIC STROKE ORTRANSIENT ISCHEMIC ATTACK: COST-EFFECTIVENESS ANALYSIS IN ITALY

Value in Health ◽

10.1016/s1098-3015(10)67612-7 ◽

2005 ◽

Vol 8 (6) ◽

pp. A151

Author(s):

G Rudelli ◽

S Roze ◽

AJ Palmer ◽

Z Hakimi ◽

J Spiesser ◽

...

Keyword(s):

Ischemic Stroke ◽

Cost Effectiveness ◽

High Risk ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Risk Patients ◽

Ischemic Attack

Cost Effectiveness Analysis Of Mitraclip In Mitral Regurgitation For High Risk Patients

Value in Health ◽

10.1016/j.jval.2014.08.1392 ◽

2014 ◽

Vol 17 (7) ◽

pp. A481

Author(s):

N. Jamet ◽

S. Bourguignon ◽

S. Marque

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Mitral Regurgitation ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Cost-Effectiveness Analysis of Protected Carotid Artery Stent Placement Versus Endarterectomy in High-Risk Patients

Journal of Endovascular Therapy ◽

10.1583/09-2938.1 ◽

2010 ◽

Vol 17 (2) ◽

pp. 224-229 ◽

Cited By ~ 14

Author(s):

Alberto Maud ◽

Gabriela Vázquez ◽

John A. Nyman ◽

Kamakshi Lakshminarayan ◽

David C. Anderson ◽

...

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Carotid Artery ◽

Stent Placement ◽

High Risk Patients ◽

Carotid Artery Stent ◽

Effectiveness Analysis ◽

Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2020.08.013 ◽

2020 ◽

Vol 14 (6) ◽

pp. 772-783

Author(s):

Kanila Perera ◽

Ning Kam ◽

Zanfina Ademi ◽

Danny Liew ◽

Ella Zomer

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Lowering Therapy ◽

Cost-effectiveness analysis of chimney/snorkel versus fenestrated endovascular repair for high-risk patients with complex abdominal aortic pathologies

The Journal of Cardiovascular Surgery ◽

10.23736/s0021-9509.19.11146-9 ◽

2020 ◽

Vol 61 (1) ◽

Cited By ~ 1

Author(s):

Gergana T. Taneva ◽

Konstantinos P. Donas ◽

Georgios A. Pitoulias ◽

Martin Austermann ◽

Frank J. Veith ◽

...

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Endovascular Repair ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Abdominal Aortic ◽

Risk Patients ◽

Aortic Pathologies

PCV81 - COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN FOR HIGH-RISK PATIENTS WITH ESTABLISHED PERIPHERAL ARTERIAL DISEASE IN CHINA

Value in Health ◽

10.1016/j.jval.2018.09.627 ◽

2018 ◽

Vol 21 ◽

pp. S106

Author(s):

Z. Lin ◽

L. Zhang ◽

X. Yang ◽

L. Liu ◽

J. Xuan

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Peripheral Arterial Disease ◽

Arterial Disease ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Risk Patients ◽

Peripheral Arterial

04 / Cost-effectiveness analysis of a prehabilitation program in high-risk patients undergoing elective major abdominal surgery

10.26226/morressier.5aeb0acc07b0d6001a79abf3 ◽

2018 ◽

Author(s):

Manuel López-Baamonde

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Abdominal Surgery ◽

Major Abdominal Surgery ◽

High Risk Patients ◽

Effectiveness Analysis ◽